neuromate robot cleared for use by US FDA
Renishaw has announced that the US Food and Drug administration (FDA) has issued clearance to market the neuromate frameless Gen II stereotactic robotic system.
Dr Abed Hammoud, CEO of Renishaw Mayfield SA said: “We are excited to launch our newest generation neuromate robotic system in the US, which is the largest global market for medical devices. Our clinical solutions and technical support teams are looking forward to working with some of the leading centres in the US and establishing robotics in the Neuro operating room.”
Visit the Renishaw website for further information on the neuromate robot.
See all stories for Renishaw
Disclaimer: Robotics Update is not responsible for the content of submitted or externally produced articles and images. Click here to email us about any errors or omissions contained within this article
